Echocardiographic screening to determine progression of latent rheumatic heart disease in endemic areas: A systematic review and meta-analysis

Abstract

Background The World Health Organisation previously recommended routine screening in school-aged children in countries with a high prevalence of rheumatic heart disease (RHD); however, it is unclear if screening-detected (latent) valve disease will inevitably evolve to a pathological lesion. Understanding the natural history of latent RHD is essential prior to recommendation of screening in endemic areas. Studies documenting the progression of latent RHD have had contrasting conclusions about the pathogenicity of latent valvular lesions. This review provides estimates of rates of progression of latent RHD. Methods and findings In this systematic review and meta-analysis, we searched EMBASE, MEDLINE, Global Index Medicus, Africa Wide, Cochrane Database of Systematic Reviews and Global Health Database for studies published before April 30, 2019. Study data were extracted from all studies which reported follow-up data on progression of latent valve lesions. Studies with control cohorts were used to calculate comparative prevalence ratios. This study is registered with PROSPERO, number CRD42019119427. We identified 12 studies reporting follow-up data on latent RHD for 950 people in 9 countries. The estimated pooled prevalence rate for progression per year of latent RHD was 5%/year (95% CI 2-8). Eight studies reported on the progression of borderline latent RHD with an estimated pooled prevalence of 2%/year (95% CI 0-4). Three studies included control groups. There was a significant increase in the risk of progression of valvular disease in the latent group compared with controls (RR = 3.57 (95%CI = 1.65-7.70, P = 0.001). The overall risk of bias was low. Given most studies included penicillin administration we were unable to document the natural history of latent RHD. Furthermore, we were unable to perform a sensitivity analysis to

Community-based prevalence of rheumatic heart disease in rural Ethiopia: Five-year follow-up

“…Also the survey data were unable to predict which subjects had continuing or progressive disease. In addition, as has been reported widely [ 9 , 10 ] there was considerable heterogeneity of the echocardiographic appearances over the course of the study with evidence of both progression and regression of valve lesions and the appearance of new disease in 8% of people who had normal echocardiograms during the initial screening.…”

Detection and management of latent rheumatic heart disease: a narrative review

“…A significant increase in the risk of progression of valvular disease in the latent group (relative risk=3.57) compared with controls was also observed in the same meta-analysis. The rate of regression of latent RHD was 15% per year 37 . This shows that even though latent RHD has a slow rate of progression, the rate of progression of latent definite RHD is substantial.…”

The “Cairo Accord”- Towards the Eradication of RHD: An Update

“…A recent metaanalysis combined data from 12 studies following up patients with latent RHD. The authors' estimated prevalence progression for latent RHD (defined variously as worsening of the WHF grade or clinical severity of disease) was 5%/year, while in the fewer studies reporting on the progression of borderline RHD, progression was as low as 2%/year (58). Although these low rates do call into question the use of echocardiography for screening, there is clearly a need for longer term studies of the natural history of latent RHD and for identifying clinical predictors of disease progression.…”